Insights

Innovative Therapeutics Cardium Therapeutics focuses on the development of advanced wound healing, bone repair, and cardiovascular treatment products, indicating opportunities to collaborate or supply specialized biomedical materials for these high-demand therapeutic areas.

Strategic Asset Disposal The company has engaged in asset monetization, such as selling its InnerCool Therapies medical device business, suggesting openness to strategic partnerships or acquisitions that expand its portfolio or distribution channels.

Funding & Growth With current revenues between 1 and 10 million dollars and recent funding of 750K, Cardium may seek additional investment or partners to scale promising treatments and accelerate commercialization efforts.

Niche Market Focus By targeting unmet medical needs with innovative biotech solutions, there are opportunities to introduce complementary technologies, devices, or services that enhance therapeutic efficacy or patient outcomes.

Technology & Data Utilization of common web technologies and analytics tools indicates a digital-savvy approach, presenting opportunities for data-driven marketing, online partnerships, and telemedicine integration to expand outreach.

Cardium Therapeutics, Inc. Tech Stack

Cardium Therapeutics, Inc. uses 8 technology products and services including WordPress, Font Awesome, Google Fonts API, and more. Explore Cardium Therapeutics, Inc.'s tech stack below.

  • WordPress
    Content Management System
  • Font Awesome
    Font Scripts
  • Google Fonts API
    Font Scripts
  • yepnope.js
    Javascript Frameworks
  • TweenMax
    Javascript Frameworks
  • jQuery
    Javascript Libraries
  • Google Analytics
    Web Analytics
  • prettyPhoto
    Web Tools And Plugins

Media & News

Cardium Therapeutics, Inc.'s Email Address Formats

Cardium Therapeutics, Inc. uses at least 1 format(s):
Cardium Therapeutics, Inc. Email FormatsExamplePercentage
FLast@cardiumthx.comJDoe@cardiumthx.com
46%
First.Last@cardiumthx.comJohn.Doe@cardiumthx.com
4%
FLast@cardiumthx.comJDoe@cardiumthx.com
46%
First.Last@cardiumthx.comJohn.Doe@cardiumthx.com
4%

Frequently Asked Questions

Where is Cardium Therapeutics, Inc.'s headquarters located?

Minus sign iconPlus sign icon
Cardium Therapeutics, Inc.'s main headquarters is located at 12255 el Camino Real Suite 250 San Diego, California 92130 United States. The company has employees across 1 continents, including North America.

What is Cardium Therapeutics, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Cardium Therapeutics, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Cardium Therapeutics, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Cardium Therapeutics, Inc.'s official website is cardiumthx.com and has social profiles on LinkedInCrunchbase.

What is Cardium Therapeutics, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
Cardium Therapeutics, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Cardium Therapeutics, Inc. have currently?

Minus sign iconPlus sign icon
As of February 2026, Cardium Therapeutics, Inc. has approximately 7 employees across 1 continents, including North America. Key team members include Chief Scientific Officer: G. R.Vp Biologics Development: B. S.Vice President Biologics Development: L. A. C.. Explore Cardium Therapeutics, Inc.'s employee directory with LeadIQ.

What industry does Cardium Therapeutics, Inc. belong to?

Minus sign iconPlus sign icon
Cardium Therapeutics, Inc. operates in the Biotechnology Research industry.

What technology does Cardium Therapeutics, Inc. use?

Minus sign iconPlus sign icon
Cardium Therapeutics, Inc.'s tech stack includes WordPressFont AwesomeGoogle Fonts APIyepnope.jsTweenMaxjQueryGoogle AnalyticsprettyPhoto.

What is Cardium Therapeutics, Inc.'s email format?

Minus sign iconPlus sign icon
Cardium Therapeutics, Inc.'s email format typically follows the pattern of FLast@cardiumthx.com. Find more Cardium Therapeutics, Inc. email formats with LeadIQ.

How much funding has Cardium Therapeutics, Inc. raised to date?

Minus sign iconPlus sign icon
As of February 2026, Cardium Therapeutics, Inc. has raised $750K in funding. The last funding round occurred on Jun 11, 2009 for $750K.

Cardium Therapeutics, Inc.

Biotechnology ResearchCalifornia, United States2-10 Employees

Cardium Therapeutics is focused on the acquisition and strategic development of new and innovative bio-medical product opportunities and businesses that have the potential to address significant unmet medical needs and definable pathways to commercialization, partnering and other economic monetizations.  Cardium’s investment portfolio includes the Tissue Repair Company and Cardium Biologics, medical technology companies primarily focused on the development of innovative therapeutic products for wound healing, bone repair, and cardiovascular indications.  In May 2009, Cardium announced completion of the enrollment for the Matrix Phase 2b clinical study to evaluate the Excellarate product candidate as a treatment for patients with non-healing diabetic ulcers.  In July 2009, Cardium completed the sale of its InnerCool Therapies medical device business to Royal Philips Electronics, the first asset monetization from the Company’s biomedical investment portfolio.

Section iconCompany Overview

Headquarters
12255 el Camino Real Suite 250 San Diego, California 92130 United States
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
2-10

Section iconMedia & News

Section iconFunding & Financials

  • $750K

    Cardium Therapeutics, Inc. has raised a total of $750K of funding over 1 rounds. Their latest funding round was raised on Jun 11, 2009 in the amount of $750K.

  • $1M$10M

    Cardium Therapeutics, Inc.'s revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $750K

    Cardium Therapeutics, Inc. has raised a total of $750K of funding over 1 rounds. Their latest funding round was raised on Jun 11, 2009 in the amount of $750K.

  • $1M$10M

    Cardium Therapeutics, Inc.'s revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.